Smart Portable Device Monitors Pacemaker and ICD Patients

A portable monitoring device keeps pacemaker, implantable cardioverter defibrillator (ICD), and insertable cardiac monitor (ICM) patients connected to their physician anywhere in the world.

The CardioMessenger Smart device provides secure, fully automatic transmission of vital information from a patient’s cardiac implant to their physician over a GSM cellular network, including automatic reports and fully customizable alerts that can be programmed to the physician’s specifications. The device transmits the data to the BIOTRONIK Home Monitoring Service Center, using wireless, coded, telemetry daily or when triggered by an event, with a call back message for patients to enable physicians to contact them whenever necessary.


BIOTRONIK Home Monitoring is intended to replace device interrogation during in-office follow-up visits, and to provide early detection of arrhythmias. It is available in over 55 countries, optimizing patient management in more than 3,800 clinics around the world. Among the features offered are intelligent early detection, customizable fully programmable alerts with options to specify alert thresholds and ranges, and callback alerts to notify the patient to contact the clinic. BIOTRONIK Home Monitoring and the CardioMessenger Smart are products of BIOTRONIK (Berlin, Germany).

“BIOTRONIK pioneered modern wireless remote monitoring technologies in the year 2000 and we continue to invest in advancements that make life more enjoyable for patients living with cardiac conditions,” said Marlou Janssen, President of BIOTRONIK. “The TRUST study demonstrated that BIOTRONIK Home Monitoring delivers greater than 90% reliability of daily remote monitoring transmissions, providing more complete data for physicians to use in optimizing patient care.”

“The clinical and economic benefits of remote monitoring have been well established over a decade of clinical studies,” said Niraj Varma, MD, of the Cleveland Clinic (CC, OH, USA), lead investigator for the TRUST Trial. “But these benefits are only realized if patients consistently use the technology. When we make the remote monitoring process easy for patients, we increase the likelihood of patient adherence, which has been demonstrated to improve health outcomes.”

Related Links:
BIOTRONIK
Cleveland Clinic